diafyt MedTech
Leipzig
About diafyt MedTech
We develop smart devices and AI software to automate diabetes management. Just call it autonomous driving for diabetics. Insulin dosing is complicated and an important concern for people with diabetes. Incorrect dosing leads to organ failure and death. No easy way exists to calculate the optimal doses. diafyt AI learns the individual insulin demand of a type 1 diabetic in one week. So people live longer while being diabetic, save money on medicine and doctor visits and have less hassle every single day. Diafyt Guide has a medical device certification for Europe. https://play.google.com/store/apps/details?id=com.diafyt.guide&gl=DE
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $683.0K
- Funding stage: Seed
- Last round: Seed (Feb 2021)
- Website: diafyt.com
- Phone: +49-151-525-71623
Industries & Categories
Artificial Intelligence (AI), Diabetes, Health Care, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/diafyt-medtech-155420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.